Fundraising FoxAmetris
1 known investors
Find your way into Ametris
Sign up to see every warm intro you have to Ametris
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ametris team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ametris provides sensor-based digital measures and digital endpoints for clinical trials, capturing data from wearable sensors and real-world patient insights. Now part of Signant Health, it supports clinical trial sponsors running decentralized, hybrid, and traditional studies alongside electronic Clinical Outcome Assessment (eCOA) capabilities.
Founders & leadership
JW
Jeremy WyattChief Executive OfficerJeremy Wyatt co-founded Ametris (now part of Signant Health), which provides wearable sensor-based data collection and digital endpoints for clinical trials. He previously worked at ActiGraph, where he developed medical-grade activity monitoring solutions and analytics for research and pharmaceutical applications.
Investors · 1
Frequently asked questions
- What does Ametris do?
- Ametris provides sensor-based digital measures and digital endpoints for clinical trials, capturing data from wearable sensors and real-world patient insights. Now part of Signant Health, it supports clinical trial sponsors running decentralized, hybrid, and traditional studies alongside electronic Clinical Outcome Assessment (eCOA) capabilities.
- Who are Ametris's investors?
- Ametris's investors include ARCHIMED Japan.